Olacing Max 0.7% (Ophthalmic Solution)
5 ml drop: ৳ 250.00
Medicine Details
Category | Details |
---|---|
Generic | Olopatadine hydrochloride |
Company | Pacific pharmaceuticals ltd |
Also available as |
Indications
- Treatment of allergic conjunctivitis
- Relief of symptoms of seasonal allergic rhinitis
- Relief of symptoms of allergic rhinitis and allergic skin conditions
Pharmacology
- Olopatadine is an antihistamine
- Works by blocking the action of histamine
- Reduces allergy symptoms
- Acts as a mast cell stabilizer
- Antagonist at histamine H1 receptors
- Inhibits release of inflammatory mediators and cytokines
- Moderate protein binding in human serum
- Plasma elimination half-life of 8 to 12 hours
- Mainly eliminated through urinary excretion
Dosage
- 0.1% Eye Drops: One drop in each affected eye two times per day
- 0.2% Eye Drops: One drop in the affected eye once a day
- 0.7% Eye Drops: One drop in each affected eye once a day
- Nasal Spray: Two sprays per nostril twice daily for adults and adolescents
- Nasal Spray: One spray per nostril twice daily for children 6 to 11 years of age
- Tablet: 5 mg dosage; adults take one tablet twice daily, children over 7 years take one tablet twice daily
Administration
- Instructions for using the Nasal Spray
- Details on cleaning the nasal spray
- Guidelines for proper insertion and dosage administration
Interaction
- No formal drug-drug interaction studies conducted for Nasal Spray
- Eliminated predominantly by renal excretion
- No expected drug interactions involving P450 inhibition or plasma protein binding
Contraindications
- Not recommended for individuals with known hypersensitivity to any component of the product
- Not recommended for use in case of allergies to the tablet
- Caution advised in consultation with a doctor for those with pre-existing medical conditions
Side Effects
- Rarely reported headaches
- Other adverse effects include asthenia, blurred vision, burning or stinging, dry eye, hyperemia, nausea, pruritus, rhinitis, sinusitis, taste perversion
Pregnancy & Lactation
- Insufficient data on teratogenic effects in pregnant women
- Caution advised for pregnant women, potential benefit to risk assessment necessary
- Potential systemic absorption in nursing mothers, caution recommended
Precautions & Warnings
- Advice on contact lens usage for individuals with red eyes
- Instructions for soft contact lens wearers
- Guidance on initial use and re-priming of Nasal Spray
- Caution against overdose and discontinuation without consultation
Use in Special Populations
- No significant differences observed in safety or effectiveness for geriatric use
Overdose Effects
- Lack of specific information on Olacing Max overdose
- Alert on potential serious consequences of excessive medication use
Therapeutic Class
- Belongs to the therapeutic class of Ophthalmic Non-Steroid drugs
Storage Conditions
- Recommendation to store at room temperature
- Protect from light exposure
- Advisory on shelf life after opening the bottle
Related Brands
- Alacot 0.1% (Ophthalmic Solution) - square-pharmaceuticals-plc
- Alacot DS 0.2% (Ophthalmic Solution) - square-pharmaceuticals-plc
- Aladay 0.1% (Ophthalmic Solution) - eskayef-pharmaceuticals-ltd
- Aladay DS 0.2% (Ophthalmic Solution) - eskayef-pharmaceuticals-ltd
- Alchek 0.1% (Ophthalmic Solution) - apex-pharmaceuticals-ltd